These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Management of weight gain in patients with schizophrenia. Aquila R J Clin Psychiatry; 2002; 63 Suppl 4():33-6. PubMed ID: 11913674 [TBL] [Abstract][Full Text] [Related]
11. Treatment-emergent tardive dyskinesia with quetiapine in mood disorders. Sharma V J Clin Psychopharmacol; 2003 Aug; 23(4):415-7. PubMed ID: 12920421 [No Abstract] [Full Text] [Related]
14. Implementing antiobesity treatment in a patient with a mood disorder. Taylor VH J Psychiatry Neurosci; 2008 Nov; 33(6):E1-2. PubMed ID: 18982178 [No Abstract] [Full Text] [Related]
15. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives. Baptista T; Kin NM; Beaulieu S; de Baptista EA Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268 [TBL] [Abstract][Full Text] [Related]
17. Implementation of monitoring and management guidelines for second-generation antipsychotics. Sernyak MJ J Clin Psychiatry; 2007; 68 Suppl 4():14-8. PubMed ID: 17539695 [TBL] [Abstract][Full Text] [Related]
18. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. Newcomer JW J Clin Psychiatry; 2007; 68 Suppl 1():20-7. PubMed ID: 17286524 [TBL] [Abstract][Full Text] [Related]
19. Antipsychotic induced weight gain in schizophrenia:mechanisms and management. Rege S Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255 [TBL] [Abstract][Full Text] [Related]